The 2010 NewX2 BioCruise brought together over 150 attendees from the biopharma communities of New York and New Jersey for an evening of cocktails, dinner, awards, and, best of all, the best networking of the year!
NYBA honorees where Dr. Ron Cohen, President & CEO of Acorda Therapeutics, Inc. and VWR’s Michael Williamson.
|